The Source for Neurovascular News and Education

April 26, 2024

 

Key Points:

- Study uses multicenter, retrospective data to create prognostic models of endovascular therapy for poor-grade aneurysmal SAH

- Age, WFNS grade, modified Fisher Grade, aneurysmal neck size, and postoperative pneumonia emerge as important predictors of outcome

 

 

Key clinical features can help predict outcome, both preoperatively and following endovascular therapy, among patients with poor-grade aneurysmal subarachnoid hemorrhage (SAH), according to 2 new prognostic models.

Details of the models, which were developed through multivariate analysis of a multicenter registry, were published online July 1, 2016, ahead of print in the Journal of Neurosurgery.

Ming Zhong, MD, of the First Affiliated Hospital of Wenzhou Medical University (Wenzhou, China), and colleagues used results from AMPAS (A Multicenter Poor-grade Aneurysm Study (AMPAS) to develop their models. Overall, 366 patients were enrolled in the registry between October 2010 and March 2012. Among them, 136 received endovascular treatment and were included in the present analysis.

At 12 months after treatment, 64 patients (47%) had a poor outcome, defined as mRS score of 4-6. Slightly more than one-third (36%) had died.

Multivariate analysis revealed that a preoperative model taking into account World Federation of Neurosurgical Societies (WFNS) grade V, modified Fisher grade, and aneurysmal neck size has excellent discrimination for outcome, with an area under the curve (AUC) of 0.86 (table 1).

A postoperative model using the same variables also produced excellent discrimination, with an AUC of 0.86 that improved to 0.87 with the addition of postoperative pneumonia (table 2).

Both models had good calibration, at P = .941 and P = .653, respectively. However, as noted in a box within the paper, their false-positive rates were approximately 25%.

First Multicenter Study of Its Kind

“To the best of our knowledge, this is the first study focused on predictors of poor outcome after endovascular treatment of poor-grade SAH using a multicenter prospective study,” write the authors. “However, our study has some limitations.” These include the fact that patients were carefully selected for endovascular therapy by a multidisciplinary team, perhaps skewing toward better outcomes. Also, most patients were treated within 72 hours, so the findings offer no guidance on the relative benefits of early vs delayed treatment.

Additionally, the authors were unable to determine an optimal cutoff value for neck size in wide-neck aneurysms, nor were they able to look into alternative repair strategies. Finally, long-term imaging data were not available.

“Further improvement of endovascular treatment of ruptured wide-neck aneurysms may help improve outcome after poor-grade [aneurysmal] SAH,” conclude the authors. “However, endovascular coiling should be carefully considered in patients with poor-grade [aneurysmal] SAH and wide-neck aneurysms, and pneumonia should be aggressively managed to improve patient outcome.”


Source:

Zhao B, Yang H, Zheng K, et al. Preoperative and postoperative predictors of long-term outcome after endovascular treatment of poor-grade aneurysmal subarachnoid hemorrhage. J Neurosurg. 2016;Epub ahead of print.

Disclosures:

  • Dr. Zhong reports no relevant conflicts of interest.

 

 

 

Monday, October 26 2020

Stroke rates for the balloon-expandable device far exceeded those of the Evolut R; conscious...

Read More »

Monday, October 26 2020

Safety goals were met in the trial, but better efficacy may require ensuring complete coverage of...

Read More »

Wednesday, September 23 2020

The findings “reinforce that this is absolutely the right thing to do and that we need to set up...

Read More »

Tuesday, July 21 2020

Whether COVID-19 adds risk by virtue of being a comorbidity or due to direct effects is unknown. A...

Read More »

Friday, May 8 2020

In some cases, large strokes are the first presentation of COVID-19 in younger patients, but...

Read More »

Monday, April 6 2020

Clopidogrel added to rivaroxaban and aspirin increased bleeding with no added protection from limb or...

Read More »

Monday, April 6 2020

Although rivaroxaban patients had more bleeding, the events were not severe and none were...

Read More »

Monday, April 6 2020

The strokes do not appear related to valve thrombosis or structural degeneration, but rather to...

Read More »

Thursday, January 23 2020

A fundamental unanswered question is whether any type of oral anticoagulation is needed in the...

Read More »

Monday, January 6 2020

Though periprocedural results look good, there are some questions about its rapid rise when...

Read More »

Wednesday, August 21 2019

In addition, an infarct in a new territory did not emerge as an independent predictor of...

Read More »

Wednesday, August 21 2019

The procedure—a hybrid of surgical and endovascular techniques—offers low stroke rates and a short...

Read More »